U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced plans for a nationwide advertising campaign encouraging Americans to adopt health wearables, such as heart rate and continuous glucose monitors. The initiative is part of the department’s broader “Making America Healthy Again” (MAHA) agenda.
Speaking before the House Energy and Commerce Committee’s Health Subcommittee, Kennedy emphasized the importance of personal health data. “My vision is that every American is wearing a wearable within four years,” he said. “It’s a way for people to take control of their health—seeing real-time impacts of food on glucose levels and heart rate.”
The announcement boosted shares of glucose-monitoring device makers. Dexcom (NASDAQ:DXCM) surged 10%, while Abbott gained 3.6% in afternoon trading.
Kennedy, a longtime advocate for preventive health and a critic of overreliance on pharmaceuticals, pointed to the cost-effectiveness of wearables compared to popular weight-loss drugs. “Ozempic costs $1,300 a month. If you can achieve similar results with an $80 wearable, that’s a better deal for Americans,” he noted. While he has criticized drugs like Novo Nordisk’s Ozempic, Kennedy supports their use for patients with morbid obesity or diabetes, when combined with exercise.
The campaign, which he described as one of the largest in HHS history, aims to shift the focus from reactive to proactive health management. Kennedy also hinted at exploring ways to subsidize wearables to make them more accessible.
J.P. Morgan analyst Robbie Marcus cautioned against assuming immediate changes in Medicare or insurance coverage for proactive monitoring, saying it’s too early to predict policy shifts.
The wearable tech market stands to benefit from this government push, as health monitoring tools become more mainstream in personal wellness strategies.


Israel Reopens Rafah Crossing, Offering Limited Relief to Gaza Patients Amid Ceasefire Efforts
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Trump Calls for “Nationalizing” Voting, Drawing Backlash Over Election Authority
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Democrats Score Surprise Texas State Senate Win, Fueling Momentum Ahead of 2026 Midterms
Trump Announces U.S.–India Trade Deal Cutting Tariffs, Boosting Markets and Energy Ties
Syria Detains Group Over Rocket Attacks on Damascus Military Airport Amid Hezbollah Allegations
U.S. and Israeli Military Leaders Hold Pentagon Talks as Tensions With Iran Escalate
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons 



